CLASS II Device recall · Reported 28 Aug 2019 · FDA Enforcement Report

HeartMate 3 LVAS Implant Kit, Sterile recalled by Thoratec

Thoratec is recalling HeartMate 3 LVAS Implant Kit, Sterile, distributed nationwide in the US. The recall was initiated on 30 Mar 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes106524/106524US: The shelf life is 36 months from date of manufacture. All batch/lot numbers 6613000 or 50000000 or higher. UDI/GMDN 00813024013297 / 47533
Quantity recalled7200 left ventricular assist systems

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2348-2019
FDA event ID
83357
Recalling firm
Thoratec, Pleasanton, CA
Classification
Class II
Status
Terminated
Recall initiated
30 Mar 2019
FDA classified
22 Aug 2019
Reported
28 Aug 2019
Type
Voluntary: Firm initiated
Customers notified by
N/A
Reason category
Sterility

Timeline

30 Mar 2019Recall initiated by company
22 Aug 2019Classified by FDA+145 days
28 Aug 2019Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Outflow Graft leaking at the pump connection during the implantation process. If the C-Ring is insufficiently seated, it renders the device nonfunctional because the Outflow Graft connection will leak during the implant procedure.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Thoratec HeartMate 3 LVAS Implant Kit, Sterile, REF 106524/106524US, RX only, Left Ventricular Assist System

Where it was distributed

Worldwide distribution. US nationwide, Australia, Austria, Brazil, Canada, Cayman Islands, Chile, Colombia, Egypt, France, Germany, Greece, Singapore, Iran, Italy, Kuwait, Lebanon, Romania, Switzerland, Thailand, United Kingdom.

Nationwide

Questions about this recall

Why was it recalled?

Outflow Graft leaking at the pump connection during the implantation process. If the C-Ring is insufficiently seated, it renders the device nonfunctional because the Outflow Graft connection will leak during the implant procedure.

Which lots are affected?

106524/106524US: The shelf life is 36 months from date of manufacture. All batch/lot numbers 6613000 or 50000000 or higher. UDI/GMDN 00813024013297 / 47533

Where was it sold?

Worldwide distribution. US nationwide, Australia, Austria, Brazil, Canada, Cayman Islands, Chile, Colombia, Egypt, France, Germany, Greece, Singapore, Iran, Italy, Kuwait, Lebanon, Romania, Switzerland, Thailand, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 83357

This product is part of a recall event; the main page for the event is Heartmate 3 Sealed Outflow Graft with Bend Relief, Sterile recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IIHeartmate 3 Sealed Outflow Graft with Bend Relief, Sterile recalledThoratecSterilityNationwide

More recalls from Thoratec

All 29

Other Other Medical Devices recalls

All 13,778